Tot Biopharm International Co Ltd historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2022-11-22 | 2.200 | 2.200 | 2.200 | 2.200 | 2.200 | 11,600 |
| 2022-11-21 | 2.250 | 2.250 | 2.250 | 2.250 | 2.250 | 400 |
| 2022-11-18 | 2.340 | 2.340 | 2.250 | 2.250 | 2.250 | 119,600 |
| 2022-11-17 | 2.250 | 2.440 | 2.250 | 2.250 | 2.250 | 286,400 |
| 2022-11-16 | 2.260 | 2.370 | 2.220 | 2.360 | 2.360 | 92,400 |
| 2022-11-15 | 2.430 | 2.460 | 2.410 | 2.450 | 2.450 | 156,800 |
| 2022-11-14 | 2.550 | 2.570 | 2.500 | 2.550 | 2.550 | 24,800 |
| 2022-11-11 | 2.550 | 2.700 | 2.500 | 2.570 | 2.570 | 51,200 |
| 2022-11-10 | 2.240 | 2.440 | 2.220 | 2.400 | 2.400 | 114,400 |
| 2022-11-09 | 2.300 | 2.590 | 2.110 | 2.490 | 2.490 | 85,200 |
| 2022-11-08 | 2.460 | 2.520 | 2.350 | 2.400 | 2.400 | 27,200 |
| 2022-11-07 | 2.500 | 2.550 | 2.500 | 2.530 | 2.530 | 12,800 |
| 2022-11-04 | 2.660 | 2.660 | 2.450 | 2.590 | 2.590 | 57,600 |
| 2022-11-03 | 2.660 | 2.660 | 2.660 | 2.660 | 2.660 | 0 |
| 2022-11-02 | 2.590 | 2.590 | 2.590 | 2.590 | 2.590 | 3,200 |
| 2022-11-01 | 2.590 | 2.590 | 2.590 | 2.590 | 2.590 | 0 |
| 2022-10-31 | 2.590 | 2.590 | 2.590 | 2.590 | 2.590 | 4,400 |
| 2022-10-28 | 2.530 | 2.530 | 2.530 | 2.530 | 2.530 | 1,200 |
| 2022-10-27 | 2.570 | 2.590 | 2.420 | 2.530 | 2.530 | 29,600 |
| 2022-10-26 | 2.580 | 2.580 | 2.580 | 2.580 | 2.580 | 0 |
| 2022-10-25 | 2.410 | 2.600 | 2.370 | 2.600 | 2.600 | 19,600 |
| 2022-10-24 | 2.590 | 2.600 | 2.580 | 2.580 | 2.580 | 5,600 |
| 2022-10-21 | 2.600 | 2.600 | 2.600 | 2.600 | 2.600 | 0 |
| 2022-10-20 | 2.620 | 2.620 | 2.620 | 2.620 | 2.620 | 400 |
| 2022-10-19 | 2.590 | 2.590 | 2.590 | 2.590 | 2.590 | 16,400 |
| 2022-10-18 | 2.410 | 2.600 | 2.410 | 2.600 | 2.600 | 4,800 |
| 2022-10-17 | 2.680 | 2.680 | 2.620 | 2.620 | 2.620 | 6,000 |
| 2022-10-14 | 2.870 | 2.870 | 2.870 | 2.870 | 2.870 | 400 |
| 2022-10-13 | 2.630 | 2.840 | 2.630 | 2.830 | 2.830 | 3,200 |
| 2022-10-12 | 2.700 | 2.710 | 2.700 | 2.710 | 2.710 | 6,000 |
| 2022-10-11 | 2.790 | 2.890 | 2.780 | 2.890 | 2.890 | 13,600 |
| 2022-10-10 | 2.770 | 2.990 | 2.760 | 2.990 | 2.990 | 13,200 |
| 2022-10-07 | 2.880 | 2.900 | 2.800 | 2.900 | 2.900 | 13,600 |
| 2022-10-06 | 2.950 | 2.950 | 2.950 | 2.950 | 2.950 | 6,000 |
| 2022-10-05 | 2.900 | 3.000 | 2.900 | 3.000 | 3.000 | 4,000 |
| 2022-10-03 | 2.900 | 3.000 | 2.900 | 3.000 | 3.000 | 5,600 |
| 2022-09-30 | 2.950 | 3.000 | 2.950 | 3.000 | 3.000 | 22,000 |
| 2022-09-29 | 2.950 | 3.000 | 2.950 | 3.000 | 3.000 | 10,000 |
| 2022-09-28 | 2.580 | 3.000 | 2.570 | 3.000 | 3.000 | 6,400 |
| 2022-09-27 | 3.000 | 3.000 | 2.950 | 3.000 | 3.000 | 4,800 |
| 2022-09-26 | 2.900 | 3.000 | 2.900 | 3.000 | 3.000 | 2,400 |
| 2022-09-23 | 2.800 | 2.800 | 2.800 | 2.800 | 2.800 | 8,000 |
| 2022-09-22 | 2.800 | 2.800 | 2.800 | 2.800 | 2.800 | 2,000 |
| 2022-09-21 | 2.830 | 2.830 | 2.830 | 2.830 | 2.830 | 3,200 |
| 2022-09-20 | 2.800 | 2.800 | 2.800 | 2.800 | 2.800 | 9,200 |
| 2022-09-19 | 2.790 | 2.880 | 2.690 | 2.690 | 2.690 | 9,200 |
| 2022-09-16 | 2.510 | 2.720 | 2.500 | 2.700 | 2.700 | 62,000 |
| 2022-09-15 | 2.610 | 2.610 | 2.610 | 2.610 | 2.610 | 4,000 |
| 2022-09-14 | 2.610 | 2.720 | 2.610 | 2.720 | 2.720 | 45,600 |
| 2022-09-13 | 2.760 | 2.760 | 2.700 | 2.700 | 2.700 | 10,800 |
| 2022-09-09 | 2.720 | 2.780 | 2.710 | 2.760 | 2.760 | 41,600 |
| 2022-09-08 | 2.890 | 2.890 | 2.890 | 2.890 | 2.890 | 0 |
| 2022-09-07 | 2.720 | 2.890 | 2.710 | 2.890 | 2.890 | 8,799 |
| 2022-09-06 | 2.890 | 2.890 | 2.890 | 2.890 | 2.890 | 0 |
| 2022-09-05 | 2.890 | 2.890 | 2.890 | 2.890 | 2.890 | 2,400 |
| 2022-09-02 | 2.900 | 2.900 | 2.900 | 2.900 | 2.900 | 0 |
| 2022-09-01 | 2.900 | 2.900 | 2.900 | 2.900 | 2.900 | 400 |
| 2022-08-31 | 2.830 | 2.830 | 2.830 | 2.830 | 2.830 | 0 |
| 2022-08-30 | 2.830 | 2.830 | 2.830 | 2.830 | 2.830 | 0 |
| 2022-08-29 | 2.830 | 2.830 | 2.830 | 2.830 | 2.830 | 0 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (HKD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.